acetylcorynoline has been researched along with oxidopamine in 1 studies
| Studies (acetylcorynoline) | Trials (acetylcorynoline) | Recent Studies (post-2010) (acetylcorynoline) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 9 | 0 | 8 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | acetylcorynoline (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WL; Chen, CS; Fu, RH; Lin, HL; Lin, SZ; Liu, SP; Lu, CH; Shyu, WC; Tsai, RT; Wang, YC; Wang, ZW; Wei, JR | 1 |
1 other study(ies) available for acetylcorynoline and oxidopamine
| Article | Year |
|---|---|
Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Appetitive Behavior; Berberine Alkaloids; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dopamine; Dopaminergic Neurons; Green Fluorescent Proteins; Humans; Molecular Structure; Muscle Cells; Nerve Degeneration; Oxidopamine; Parkinsonian Disorders; Repressor Proteins | 2014 |